Table 2 CUP subsets and outcome.
From: Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1
| Subgroups | (#) | (%) |
|---|---|---|
| Favorable | 50 | 62 |
| Unfavorable | 31 | 38 |
| Treatment | (#) | (%) |
| Chemotherapy | 64 | 78 |
| Radiotherapy | 4 | 6 |
| Median survival | (months) | |
| All cases | 10.5 | |
| favourable cases | 11.5 | |
| unfavorable cases | 8.5 |